Generic drug settlement offers compensation for price-fixing allegations

A massive settlement has been reached following allegations that multiple pharmaceutical companies, including Sandoz and Glenmark, conspired to fix prices and reduce competition for generic drugs.

Individuals in the United States who purchased applicable generic medications between May 1, 2009, and December 31, 2019, may be eligible for compensation. The affected medications include treatments for diabetes, cancer, ADHD, and various topical conditions.

Forty-eight Attorneys General have established a composite website to help potential claimants verify their information and report claims. While many residents are eligible, specific restrictions apply to residents of Louisiana regarding settlement payments.